ALNYLAM PHARMACE.DL-,0001ALNYLAM PHARMACE.DL-,0001ALNYLAM PHARMACE.DL-,0001

ALNYLAM PHARMACE.DL-,0001

No trades
See on Supercharts

DUL fundamentals

ALNYLAM PHARMACE.DL-,0001 financial statements, including revenue, expenses, profit, and loss

The total revenue of DUL for the last quarter is 398.39 M EUR, and it's 43.89% lower compared to the previous quarter. The net income of Q4 23 is -124.91 M EUR.

Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth